Amylyx Pharmaceuticals, Inc.
27.20USD
-1.3700 (-4.80%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on AMLX.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$0.37▼ | -$0.33 | 2 | 4 |
| Next quarter | -$0.36▼ | -$0.34 | 4 | 3 |
| Current year | -$1.48▼ | -$1.38 | 2 | 4 |
| Next year | -$1.09▲ | -$1.27 | 3 | 3 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.36 | -$0.39 | -0.03 (-9.0%) |
| 2026-03-31 | -$0.34 | -$0.37 | -0.03 (-8.7%) |
| 2025-12-31 | -$0.34 | -$0.3 | +0.04 (+12.2%) |
| 2025-09-30 | -$0.43 | -$0.37 | +0.06 (+13.9%) |
81 ratings from 12 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Citigroup | Maintained | Buy | $32 $39 | Oct 15, 2026 |
| Guggenheim | Maintained | Buy | $55 $57 | Aug 27, 2026 |
| Mizuho | Maintained | Outperform | $30 $42 | Aug 19, 2026 |
| Guggenheim | Maintained | Buy | $40 $55 | Aug 19, 2026 |
| Baird | Maintained | Outperform | $28 $52 | Aug 19, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $34 $55 | Aug 18, 2026 |
| Mizuho | Maintained | Outperform | $24 $30 | Aug 17, 2026 |
| Citigroup | Maintained | Buy | $20 $26 | Aug 3, 2026 |
| Mizuho | Maintained | Outperform | $21 $24 | Jul 20, 2026 |
| Guggenheim | Maintained | Buy | $30 $40 | Jun 25, 2026 |
| Mizuho | Maintained | Outperform | $19 $21 | Apr 28, 2026 |
| HC Wainwright & Co. | Reiterated | Buy | $34 | Mar 25, 2026 |
| Guggenheim | Maintained | Buy | $25 $30 | Mar 19, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $28 $34 | Mar 4, 2026 |
| Stifel | Initiated | Buy | $21 | Mar 3, 2026 |
| B of A Securities | Maintained | Buy | $15 $19 | Feb 20, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $20 $28 | Feb 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $16 $20 | Nov 7, 2025 |
| Citigroup | Maintained | Buy | $12 $20 | Oct 17, 2025 |
| Baird | Maintained | Outperform | $10 $19 | Oct 16, 2025 |
| B of A Securities | Maintained | Buy | $14 $16 | Oct 3, 2025 |
| Goldman Sachs | Maintained | Buy | $10 $20 | Sep 16, 2025 |
| Guggenheim | Maintained | Buy | $17 $25 | Sep 15, 2025 |
| B of A Securities | Maintained | Buy | $10 $14 | Aug 28, 2025 |
| Guggenheim | Initiated | Buy | $17 | Jun 24, 2025 |
87 filings from 15 insiders · 7 buy / 7 sell over 6m
Officers and directors of AMLX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| MILNE GEORGE M JRDirector | Sell | 30.0k | $27.70 | $831k | Oct 5, 2026 |
| Bedrosian Camille LOfficer, Chief Medical Officer | Sell | 2.1k | $33.09 | $69k | Sep 10, 2026 |
| Bedrosian Camille LOfficer, Chief Medical Officer | Sell | 7.9k | $32.21 | $256k | Sep 10, 2026 |
| FRATES JAMES MOfficer, Chief Financial Officer | Sell | 1.0k | $33.23 | $35k | Sep 10, 2026 |
| FRATES JAMES MOfficer, Chief Financial Officer | Sell | 9.8k | $32.27 | $315k | Sep 10, 2026 |
| Mazzariello GinaOfficer, Chief Legal Officer | Sell | 11 | $33.34 | $367 | Sep 10, 2026 |
| Mazzariello GinaOfficer, Chief Legal Officer | Sell | 9.5k | $32.46 | $309k | Sep 10, 2026 |
| Cohen Joshua BDirector; Officer, Co-Chief Executive Officer | Sell | 919 | $33.15 | $30k | Sep 10, 2026 |
| Cohen Joshua BDirector; Officer, Co-Chief Executive Officer | Sell | 29.5k | $32.16 | $950k | Sep 10, 2026 |
| Klee Justin B.Director; Officer, Co-Chief Executive Officer | Sell | 1.4k | $33.16 | $48k | Sep 10, 2026 |
| Klee Justin B.Director; Officer, Co-Chief Executive Officer | Sell | 29.0k | $32.13 | $933k | Sep 10, 2026 |
| Firestone KarenDirector | ExerciseStock Option (right to buy) | 25.0k | — | — | Aug 31, 2026 |
| Firestone KarenDirector | ExerciseStock Option (right to buy) | 25.0k | — | — | Aug 31, 2026 |
| Firestone KarenDirector | Exercise | 25.0k | $5.05 | $126k | Aug 31, 2026 |
| Firestone KarenDirector | Exercise | 25.0k | $1.76 | $44k | Aug 31, 2026 |
| FRATES JAMES MATTHEWChief Financial Officer | Grant | 22.8k | — | — | Aug 18, 2026 |
| BEDROSIAN CAMILLE LOfficer | Grant | 22.8k | — | — | Aug 18, 2026 |
| MAZZARIELLO GINAOfficer | Grant | 21.3k | — | — | Aug 18, 2026 |
| KLEE JUSTIN BChief Executive Officer | Grant | 60.0k | — | — | Aug 18, 2026 |
| COHEN JOSHUA BARRYChief Executive Officer | Grant | 60.0k | — | — | Aug 18, 2026 |
No analyst notes on AMLX yet.
Members whose judged calls on AMLX have played out most reliably.
No settled calls on AMLX yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
11 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 11 | 1 | 0 | 0 | Buy2.08 |
| 1 mo ago | 0 | 11 | 1 | 0 | 0 | Buy2.08 |
| 2 mo ago | 0 | 11 | 1 | 0 | 0 | Buy2.08 |
| 3 mo ago | 0 | 10 | 1 | 0 | 0 | Buy2.09 |